首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model
【24h】

Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model

机译:在兔组织笼感染模型中用暴露于左氧氟沙星的大肠杆菌测试突变体选择窗口假说

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to test the mutant selection window (MSW) hypothesis with Escherichia coli exposed to levofloxacin in a rabbit model and to compare in vivo and in vitro exposure thresholds that restrict the selection of fluoroquinolone-resistant mutants. Local infection with E. coli was established in rabbits, and the infected animals were treated orally with various doses of levofloxacin once a day for five consecutive days. Changes in levofloxacin concentration and levofloxacin susceptibility were monitored at the site of infection. The MICs of E. coli increased when levofloxacin concentrations at the site of infection fluctuated between the lower and upper boundaries of the MSW, defined in vitro as the minimum inhibitory concentration (MIC99) and the mutant prevention concentration (MPC), respectively. The pharmacodynamic thresholds at which resistant mutants are not selected in vivo was estimated as AUC24/MPC 20 h or AUC24/MIC 60 h, where AUC24 is the area under the drug concentration time curve in a 24-h interval. Our finding demonstrated that the MSW existed in vivo. The AUC24/MPC ratio that prevented resistant mutants from being selected estimated in vivo is consistent with that observed in vitro, indicating it might be a reliable index for guiding the optimization of antimicrobial treatment regimens for suppression of the selection of antimicrobial resistance.
机译:本研究的目的是在兔模型中用暴露于左氧氟沙星的大肠杆菌测试突变体选择窗口(MSW)假设,并比较限制氟喹诺酮耐药性突变体选择的体内和体外暴露阈值。在兔中建立了大肠杆菌的局部感染,并且连续五天每天口服一次不同剂量的左氧氟沙星治疗被感染的动物。在感染部位监测左氧氟沙星浓度和左氧氟沙星敏感性的变化。当感染部位的左氧氟沙星浓度在MSW的上下边界之间波动时,大肠杆菌的MIC会增加,这在体外分别定义为最低抑制浓度(MIC99)和突变预防浓度(MPC)。在体内未选择抗性突变体的药效学阈值估计为AUC24 / MPC> 20 h或AUC24 / MIC> 60 h,其中AUC24是24小时间隔内药物浓度时间曲线下的面积。我们的发现表明,MSW存在于体内。在体内估计的阻止选择抗性突变体的AUC24 / MPC比值与在体外观察到的一致,这表明它可能是指导优化抗菌治疗方案以抑制选择抗性的可靠指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号